2-Bromo-5-fluoro-4-methylanisole is being used in studies for the design and preparation of (arylcarbamoylphenoxy)acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.